Skip to main content
Main menu
Members
Membership
Why Join
Join
Renew
Committees
40 under 40 Program
Diversity & Inclusion Working Group
Discover ABI
Member Resources
About Resources
ABI Blog Exchange
ABI Law Review
Law
Volo
Opinions
Global Insolvency
Ch.11 Commission
Consumer Commission
Veterans Task Force
St. John's Case Blog
Education & Events
Education
Restructuring Masterclass
Bookstore
E-learning
Eye On Bankruptcy
Track your CLE/CPE
Events
Calendar of Events
Call for Abstracts
Conference Materials
Sponsors & Exhibitors
ABI Events App
Newsroom
News
Rochelle Daily Wire
Legislative News
Press Releases
Statistics
Supreme Court
Headlines
Insolvency Informer
SBRA
ABI Journal
Latest Issues
Advertise
Archived Articles
Journal Authors
Journal Columns
Journal Topics
ABI Journal App
Submission Guidelines and Deadlines
Subscribe to ABI Journal
ABI Media
Podcasts
Videos
Endowment
Giving
Ways to Give
Newsletters
Contributors
Founders Club
Endowment Committees
Research
Research Grants
Resident Scholars
ABI International
ABI International
Global Insolvency
ABI International Board Committee
About
About ABI
Partners
Annual Reports
Career Opportunities
Contact Us
Leadership
Login
User account menu
Login
Register
Log in
Teva Pharm Expects to Start Paying U.S. Opioid Settlement in 2023 - CEO
Home
Newsroom
29
June
2025
Article Tags
Claims
Health Care
Mass Torts
Please note that in order to view the content for the
Bankruptcy Headlines
you must either
Sign in
if you are already an ABI member, or otherwise you may
Become an ABI Member
